Evaluation of Amentoflavone Metabolites on PARP-1 Inhibition and the Potentiation on Anti-Proliferative Effects of Carboplatin in A549 Cells.

Baolin Wang,Xiaolong Hu,Rong Wang,Huan Long,Hao Wang
DOI: https://doi.org/10.1016/j.bmcl.2021.128480
IF: 2.94
2022-01-01
Bioorganic & Medicinal Chemistry Letters
Abstract:The present study aims to determine the major metabolites of amentoflavone (AMF) and further evaluate their inhibitory effects on PARP-1. First, different fractions (Frs. 1-9), which were collected according to retention time of AMF metabolites based on UHPLC-QTOF-MS/MS qualitative analysis, were evaluated on their inhibitory effects against PARP-1. Then, two mono-sulfate metabolites in the fractions with potent PARP-1 inhibitory effect were targetedly semi-synthesized. Moreover, three mono-sulfate conjugates (compound 8, 9 and 10), including one disulfate conjugate (compound 10), were isolated and their structures were fully elucidated by UHPLC-QTOF-MS/MS and NMR. Finally, the binding mode of compound 8 (amentoflavone-4‴-O-sulfate) toward PARP-1 and its potentiation on carboplatin (CBP) in A549 cells were investigated. This study was the first report on bioactivity evaluation of AMF metabolites in rat bile on PARP-1 and the potentiation of compound 8 on carboplatin (CBP) in A549 cells in vitro. This paper also provided scientific basis for the AMF metabolites on PARP-1 inhibition and chemosensitization.
What problem does this paper attempt to address?